# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 5

Extent: E+W+S+N.I.

For regulation 8 (amendment of Schedule 1 (further provisions for classification of medicinal products)) substitute—
“8 In Schedule 1—
(a) in paragraph 1—
(i) in sub-paragraph (b), insert “ UK ” before “marketing authorisation”;
(ii) in sub-paragraphs (e)(i), (f)(i) and (g)(i), for “marketing authorisation” substitute “ UK marketing authorisation, EU marketing authorisation, Article 126a authorisation or parallel import licence ”; and
(b) in paragraph 4, for “marketing authorisation” substitute “ UK marketing authorisation, EU marketing authorisation, Article 126a authorisation, parallel import licence ”.”.

---
Source: https://www.legislation.gov.uk/uksi/2020/1488/schedule/2/paragraph/5 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.